The behavioral effects of felbamate were assessed in 20 persons (ages 2 to 19 years) who were participating in a compassionate plea protocol for children with Lennox-Gastaut syndrome. Parents completed a questionnaire concerning aspects of behavioral change once all medications were in a constant regimen. Significant improvements were suggested in social functioning, intellectual functioning, motor functioning, attention and concentration, alertness, initiative, variability In performance, and memory. There was a tendency for these effects to reverse when the drug was discontinued.
Get full access to this article
View all access options for this article.
References
1.
Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). New England Journal of Medicine, 1993, 328, 29–33.
2.
LeppikI. E.GravesN. M.Potential antiepileptic drugs: felbamate. In LevyR. H.DreifussF. E.MattsonR. H.MeldrumB. S.PenryJ. K. (Eds.), Antiepileptic drugs. (3rd ed.) New York: Raven, 1989. Pp. 983–990.
3.
NeidermeyerE.DegenR.The Lennox-Gastaut Syndrome. New York: Liss, 1988.
